Data for Quadruplet Therapies Could Alter Frontline SOC for Transplant-Ineligible Multiple Myeloma

Muhamed Baljevic, MD, FACP, discusses the investigation of frontline quadruplet therapies in transplant-ineligible multiple myeloma.

Related Keywords

Tennessee ,United States ,Muhamed Baljevic ,Vanderbilt Ingram Cancer Center Protocol ,Plasma Cell Disorders Research ,Vanderbilt Ingram Cancer Center ,Division Of Hematology Oncology ,Hematology Oncology ,Vanderbilt Amyloidosis Multidisciplinary Program ,Vanderbilt Ingram Cancer Center Protocol Review ,Monitoring System ,Vanderbilt Stem Cell Transplant ,Cellular Therapy ,